EUVIMEDEUVIMED entdecken
Crossref

Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells

Tuğcan Korak iD, Merve Gulsen Bal Albayrak, Murat Kasap, Sevinc Yanar iD, Gurler Akpinar

Scandinavian Journal of Immunology · 2026

DOI: 10.1111/sji.70085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2026. Verfasst von Tuğcan Korak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey. Hauptthemen laut MEDLINE: Killer Cells, Natural, Signal Transduction, Triple Negative Breast Neoplasms, Cytotoxicity, Immunologic. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options, and impairment of natural killer (NK) cell cytotoxicity within the tumour microenvironment remains a major challenge. The present study investigated the role of the NogoA/Nogo receptor 1 (NgR1) axis in modulating NK cell–mediated cytotoxicity against TNBC cells. NK‐92 and MDA‐MB‐231 cells were co‐cultured at optimised effector‐to‐target ratios, followed by treatment with the NgR1 antagonist NEP1‐40. Cell viability was assessed by WST‐1 assay, apoptosis was evaluated using AO/DAPI staining, gene expression was analysed by RT‐PCR, and downstream pathways together with immune infiltration were examined in silico. Blockade of NogoA/NgR1 signalling increased NK‐92–mediated cytotoxicity ( p < 0.0001). NEP1‐40 reduced tumour cell viability from approximately 81% to 50% and significantly increased apoptotic cell death ( p < 0.0001). Expression analysis revealed repression of oncogenic and migration‐associated genes, including CDK4, MYC, NF‐κB1, VEGFA, FGF1, N‐cadherin and CD155, consistent with enhanced NK cell–mediated cytotoxicity and reduced tumour immune evasion. Functional annotation identified the PI3K/AKT pathway alongside cell cycle–related processes as candidate downstream mechanisms, while correlation analysis showed that most NogoA‐regulated genes were significantly negatively associated with NK cell infiltration ( p < 0.05), highlighting their role in immune escape. These findings suggest that NogoA regulates both tumour behaviour and immune remodelling in TNBC by enhancing NK cell–mediated cytotoxicity, promoting apoptosis and suppressing immune evasion pathways. Targeting the NgR1/NogoA axis may therefore represent a promising approach to strengthen NK cell–based immunotherapy, offering a novel therapeutic avenue in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalSignal TransductionTriple Negative Breast NeoplasmsCytotoxicity, ImmunologicNogo Receptor 1HumansFemaleMDA-MB-231 CellsApoptosisCell Line, TumorCell SurvivalTumor Microenvironment

Stichwörter der Autor:innen

NEP1‐40NgR1NogoAbreast cancerimmunologynatural killer cells

Substanzen

Nogo Receptor 1

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Department of Molecular Gastroenterology and Hepatology, Gastroenterology and Hepatology Institute, Kocaeli University, Kocaeli, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

ORCID-Profile: Tuğcan Korak, Sevinc Yanar

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Korak, T., Albayrak, M. G. B., Kasap, M., Yanar, S., & Akpinar, G. (2026). Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70085

Vancouver

Korak T, Albayrak MGB, Kasap M, Yanar S, Akpinar G. Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells. Scandinavian Journal of Immunology. 2026. doi:10.1111/sji.70085

BibTeX
@article{Korak2026,
  author = {Korak, Tuğcan and Albayrak, Merve Gulsen Bal and Kasap, Murat and Yanar, Sevinc and Akpinar, Gurler},
  title = {Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells},
  journal = {Scandinavian Journal of Immunology},
  year = {2026},
  doi = {10.1111/sji.70085}
}
Kostenlos starten →